12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, health care stocks saw significant movements. Twist Bioscience, Jaguar Health, Tandem Diabetes Care, Indaptus Therapeutics, Ardelyx, and NKGen Biotech were among the gainers, with notable increases in their stock prices following earnings reports. Conversely, Cue Biopharma, Cardiff Oncology, Orchestra BioMed Holdings, Aptevo Therapeutics, Allarity Therapeutics, and Varex Imaging experienced declines.
May 02, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jaguar Health's shares increased by 13.91% to $0.33, with a market cap of $95.9 million.
Jaguar Health's stock price increase indicates a positive market response, possibly due to favorable news or market conditions.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tandem Diabetes Care's stock increased by 12.25% to $41.04 after Q1 earnings, with a market cap of $2.6 billion.
The rise in TNDM's stock price post-Q1 earnings suggests the earnings report was favorable, leading to positive investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Twist Bioscience's stock rose 14.1% to $36.51 after Q2 earnings, with a market cap of $2.1 billion.
The significant increase in TWST's stock price following the Q2 earnings report suggests positive investor reaction, likely due to better-than-expected earnings results.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Cardiff Oncology's stock decreased by 6.7% to $4.18 after Q1 earnings, with a market value of $186.8 million.
The decrease in CRDF's stock price post-Q1 earnings suggests the earnings report may have not met investor expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Cue Biopharma's shares declined by 7.5% to $1.74, with a market cap of $84.6 million.
The decline in CUE's stock price in after-market trading could indicate negative investor sentiment or reaction to company news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Varex Imaging's shares decreased by 5.67% to $15.5 after Q2 earnings, with a market value of $629.5 million.
The drop in VREX's stock price following Q2 earnings indicates the results may have disappointed investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90